Epidemiology of Bloodstream Infections at a Cancer Center

Abstract

The identification of the microbiology profile of BSI and the recognition of possible risk factors in high-risk cancer patients may help in planning and conducting more effective infection control and preventive measures, and may also allow further analytical studies for reducing severe infectious complications in such groups of patients.

Prevalence of fungemia in a tertiary hospital: Analysis of the last decade

“…This increase was consistent with epidemiological data from other national and international hospitals. 6,13,[19][20][21] The increased prevalence of fungemia in hospital services may be related to advances in health care, which allowed greater survival of immunosuppressed patients. 19 The frequent use of invasive instruments and materials in hospital care, and the indiscriminate use of broad-spectrum antimicrobials also contributed to the increase in fungemia.…”

Bloodstream Infections in Patients with Solid Tumors: Associated Factors, Microbial Spectrum and Outcome

“…insertion of peripheral or central venous catheter or urinary catheter) or diagnostic (e.g. bronchoscopy, colonoscopy) procedure that could have caused transient BSI, if performed during the 10 days prior to the onset of infection [20].…”

“…Radiotherapy or chemotherapy were considered recent if administered within the month preceding the BSI [20].…”

Fungemia in a university hospital: an epidemiological approach

“…Early detection of risk factors for the development of fungemia, such as administration of broadspectrum antibiotics, use of multiple lumen catheters, mechanical ventilation, parenteral nutrition, and colonization fungal, has led to empirical treatment to reduce the high mortality rate associated with fungal infections 13 . Other factors cited as underlying conditions are malignant diseases, use of corticosteroids, cancer chemotherapy, radiation, malnutrition, and advanced age; they are identified as adjuvant agents in the onset of fungemia 5,7 .…”